Westpac Banking Corp’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-32,331
| Closed | -$1.34M | – | 783 |
|
|
2022
Q3 | $1.34M | Sell |
32,331
-22,849
| -41% | -$946K | 0.02% | 570 |
|
|
2022
Q2 | $3.29M | Buy |
55,180
+5,800
| +12% | +$346K | 0.04% | 442 |
|
|
2022
Q1 | $3.59M | Sell |
49,380
-1,400
| -3% | -$102K | 0.04% | 443 |
|
|
2021
Q4 | $4.27M | Sell |
50,780
-2,300
| -4% | -$193K | 0.04% | 429 |
|
|
2021
Q3 | $4.79M | Buy |
53,080
+4,598
| +9% | +$415K | 0.05% | 426 |
|
|
2021
Q2 | $4.62M | Sell |
48,482
-2,089
| -4% | -$199K | 0.05% | 452 |
|
|
2021
Q1 | $5.76M | Buy |
50,571
+7,100
| +16% | +$808K | 0.06% | 376 |
|
|
2020
Q4 | $6.02M | Buy |
43,471
+4,484
| +12% | +$621K | 0.07% | 365 |
|
|
2020
Q3 | $3.2M | Buy |
38,987
+3,900
| +11% | +$321K | 0.04% | 427 |
|
|
2020
Q2 | $2.74M | Buy |
+35,087
| New | +$2.74M | 0.04% | 443 |
|